Composition Including Benzylaminoethanol Derivative as Active Ingredient for Prevention or Treatment of Metabolic Disease
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
N/A
Issued Date -
Mar 6, 2025
app pub date -
Jul 28, 2022
filing date -
Jul 28, 2022
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The present invention relates to a pharmaceutical composition and a functional food composition for preventing or treating metabolic disorder, comprising a benzylaminoethanol derivative as an active ingredient. The composition of the present invention shows little or no cytotoxicity while significantly reducing metabolic disorder indicators by significantly inhibiting adipocyte differentiation and lipid accumulation, and thus may be useful as an efficient therapeutic agent for metabolic disorder that has few side effects even upon long-term administration.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully